SEC Tracker
Get the app

INSMED INSM

Michael Alexander Smith (Officer) plans to sell 24,272 INSM shares, about $3.5M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Sep 2, 2025
  2. Broker: Merrill Lynch
  3. Shares acquired by: Stock Plan Activity
  4. 10b5-1 plan adopted: Feb 27, 2025

All of Michael Alexander Smith's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 1,354 shares at $141.16 on Sep 2, 2025 · Form 4
  • Sold 1,100 shares at $142.06 on Sep 2, 2025 · Form 4
  • Sold 7,391 shares at $143.16 on Sep 2, 2025 · Form 4
  • Sold 8,300 shares at $144.16 on Sep 2, 2025 · Form 4
  • Sold 4,944 shares at $145.18 on Sep 2, 2025 · Form 4
  • Sold 1,183 shares at $145.89 on Sep 2, 2025 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when INSMED files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Biogen BIIB public float $18.4B, Jun 30, 2025
  2. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  3. BeOne Medicines ONC public float $14.7B, Jun 30, 2025
  4. United Therapeutics UTHR public float $11.2B, Jun 30, 2025
  5. Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025